HOME Top Market Reports Continuous Renal Replacement Therapy Market by Product (Systems, Disposables (Hemofilters & Bloodlines), & Dialysate), Modality (SCUF, CVVH, CVVHD, CVVHDF), Adoption & Procedures, and Region (Europe, North America, Asia-Pacific) - Forecast to 2022

Continuous Renal Replacement Therapy Market by Product (Systems, Disposables (Hemofilters & Bloodlines), & Dialysate), Modality (SCUF, CVVH, CVVHD, CVVHDF), Adoption & Procedures, and Region (Europe, North America, Asia-Pacific) - Forecast to 2022

By: marketsandmarkets.com
Publishing Date: July 2017
Report Code: MD 3842

Discount on Reports  

  Speak to Analyst Enquiry Before Buying Webinar
purchase report
download pdf  request for customisation


Rising number of acute kidney injury to drive market demand for continuous renal replacement therapy market; reaching a value of USD 1.53 billion by 2022

The global continuous renal replacement therapy (CRRT) market has been segmented on the basis of product, modality, and region. Based on product, the dialysates and replacement fluids segment commanded the largest share of the global CRRT market in 2016. This large market share is mainly attributed to factors such as high volume requirement of dialysates & replacement fluids, high cost of these components, and development & commercialization of novel renal replacement solutions.

The global CRRT market is estimated to reach USD 1.53 billion by 2022; growing at a CAGR of 7.0% during the forecast period. Increasing prevalence of AKI and renal disorders, growing number of ICU patients, rapid growth in the aging population, and clinical advantages of CRRT over intermittent blood purification techniques are some key factors propelling the growth of this market.

In 2016, Europe held the largest share of the market. However, the developing Asia-Pacific countries including China and India are expected to emerge as the new revenue-generating regions for prominent market players during 2017-2022. The growth of this Asia-Pacific market is attributed to the growing patient population, increasing sepsis incidence, increasing prevalence of hypertension and diabetes (which are the major causes for developing AKI), high use of CRRT in Australia and Japan, improving healthcare expenditure, and increasing accessibility to CRRT for AKI treatment.

In 2016, Baxter International Inc. (U.S.) held the leading position in the market. Over the past three years, the company has adopted product launches & enhancements, strategic acquisitions, and market expansion as its key business strategies to ensure its dominance in this market. Fresenius Medical Care AG & Co. KGAA (Germany), Nikkiso Co., Ltd. (Japan), B. Braun Melsungen AG (Germany), Nxstage Medical, Inc. (U.S.), Asahi Kasei Medical Co., Ltd. (Japan), Bellco S.R.L. (Italy) Infomed SA (Switzerland), Medica S.p.A (Italy), Medical Components, Inc. (U.S.), and Toray Medical Company Limited (Japan)  were few other key players operating in the continuous renal replacement therapy market.

Target Audience

  • CRRT manufacturers, suppliers, and distributors
  • CRRT service providers
  • Renal research laboratories
  • Renal associations and organizations
  • Hospitals and critical care units
  • Academic medical centers and universities
  • Business research and consulting service providers

To know about the assumptions considered for the study, download the pdf brochure

Scope of the Report

This research report categorizes the CRRT market into the following segments:

CRRT market, by Type

  • Dialysates and Replacement Fluids
  • Disposables
  • Hemofilters
  • Bloodline Sets
  • Other Disposables
  • Systems

CRRT market, by Modality

  • Continuous Venovenous Hemofiltration (CVVH)
  • Continuous Venovenous Hemodialysis (CVVH)
  • Continuous Venovenous Hemodiafiltration (CVVH)
  • Slow Continuous Filtration (SCUF)

CRRT market, by Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • RoE
  • Asia-Pacific
    • Japan
    • China
    • India
    • RoAPAC
  • Rest of the World

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for CRRT market report:

Product Analysis

  • Product Matrix, which gives a detailed comparison of the product portfolios of the top five companies

Company Information

  • Detailed analysis and profiling of additional market players (Up to 5)

Growing demand of hemofilters to drive the global CRRT market to reach USD 1.53 billion by 2022

Hemofilters or artificial kidneys are one of the major components in a CRRT system. These filters usually contain a semipermeable membrane in a hollow-fiber design. This design enables blood to flow inside the hollow fibers and, at the same time, allows the dialysate to flow outside the fibers. The membrane type and surface area help to determine solute and fluid removal during a CRRT procedure.

The hemofilters market is projected to reach largest market share of overall CRRT market for disposables by 2022, largely due to development of new hemofilters, the rise in the number of CRRT procedures, and growing focus of manufacturers on expanding their distribution channels. Large number of clinical studies is currently underway to understand the effects of hemofilters on anticoagulating agents during CRRT procedures in critically ill patients are likely to propel further growth of the hemofilters during the forecast period.

The implementations of localized manufacturing across emerging markets (such as China, India, and Brazil) by major market players are expected to increase the availability of hemofilters at competitive prices.

Market Dynamics

Continuous Renal Replacement Therapy (CRRT) Market

Rising adoption of continuous venovenous hemofiltration (CVVH) among critical care providers, to drive CRRT industry growth during forecast period

Continuous Venovenous Hemofiltration (CVVH)

The widespread adoption of this modality for the treatment of AKI due to the procedural benefits poses such as high filtrate flow in CVVH that enhances the performance of solute removal, highly effective for the removal of large molecules from patients with reduced renal function or kidney failure, solutes can be removed in large quantities while easily maintaining a net zero or even a positive fluid balance in the patient. Furthermore, growing demand of continuous venovenous hemofiltration is augmented by its effectiveness in removing big molecules while maintaining a positive fluid balance in patients and a large number of ongoing research studies and clinical trials to establish the safety and efficacy profile for CRRT products.

Continuous venovenous hemodiafiltration to register the highest CAGR during the forecast period

Continuous Renal Replacement Therapy (CRRT) Market

Continuous Venovenous Hemodiafiltration (CVVHDF)

In this modality, blood is passed through a hemofilter and a dialysate is injected on the other side of the semi-permeable membrane, combining the filtration and dialysis processes. Positive demand growth of CVVHDF is driven by the key advantages such as better clearance of medium-sized solutes as compared to hemodialysis (due to the combination of hemofiltration with the continuous HD procedure), proper acid-base balance without additional intervention, and a significant reduction in CRRT-related phosphate depletion.

Continuous Venovenous Hemodialysis (CVVHD)

This technique removes solutes by diffusion using dialysates; replacement fluids are not required in this therapy. Effectiveness of this modality in removing small and medium-sized molecules, increasing incidences of acute renal failure and lactic acidosis are the key factors propelling the demand for CVVHD market.

Slow Continuous Ultrafiltration (SCUF)

SCUF primarily removes water from the bloodstream through ultrafiltration. This process removes excess water at a very slow ultrafiltration rate. The modest market share of this segment is mainly due to several factors such as  increasing use in resolving fluid overloads, pulmonary edemas, & congestive heart failure; very low adoption owing to insufficiencies in waste clearance considering the severity of patients; and the ultrafiltrate utilized in SCUF is low, which helps in maintaining the stability of a patient’s vital signs and does not have any major side effects.

Key Questions

  • What are the key growth strategies adopted by major continuous renal replacement therapy market players to maintain their market position across key geographies?
  • What is the existing developmental pipeline of major modalities among key CRRT manufacturers?
  • Growing number of Acute Kidney Injury (AKI) patients is a key trend in CRRT market. What impact AKI incidences will have on CRRT market during the forecast period?
  • What alternative technologies/therapies are currently being used for AKI worldwide? What competition they pose for key CRRT market players.

Table of Contents

1 Introduction (Page No. - 15)
    1.1 Objectives of the Study
    1.2 Market Definition
    1.3 Market Scope
           1.3.1 CRRT Market Segmentation
           1.3.2 CRRT Market: Geographic Scope
           1.3.3 Years Considered for the Study
    1.4 Currency
    1.5 Limitations
    1.6 Stakeholders

2 Research Methodology (Page No. - 19)
    2.1 Research Approach
    2.2 Secondary and Primary Research Methodology
           2.2.1 Secondary Research
                    2.2.1.1 Key Data From Secondary Sources
           2.2.2 Primary Research
                    2.2.2.1 Key Data From Primary Sources
                    2.2.2.2 Key Industry Insights
    2.3 Market Size Estimation Methodology
    2.4 Market Data Validation and Triangulation
    2.5 Assumptions for the Study

3 Executive Summary (Page No. - 32)

4 Premium Insights (Page No. - 35)
    4.1 CRRT: Market Overview (2017)
    4.2 Global CRRT Market, By Product, 2017 vs 2022
    4.3 CRRT Market, By Modality and Region (2017)
    4.4 Geographic Snapshot: CRRT Market (2017)

5 Market Overview (Page No. - 38)
    5.1 Introduction
    5.2 Market Dynamics
           5.2.1 Drivers
                    5.2.1.1 Increasing Global Incidence of AKI
                    5.2.1.2 Growing Number of Icu Patients
                    5.2.1.3 Clinical Advantages of CRRT Over Intermittent Blood Purification Techniques
                    5.2.1.4 Technological Advancements and New Product Launches
                    5.2.1.5 Increasing Incidence of Sepsis
                    5.2.1.6 Growing Prevalence of Diabetes and Hypertension
           5.2.2 Restraints
                    5.2.2.1 High Procedural Cost of CRRT
                    5.2.2.2 Stringent Regulatory Guidelines for CRRT in North America
           5.2.3 Opportunities
                    5.2.3.1 Emerging Markets
                    5.2.3.2 Increasing Applications of CRRT
                               5.2.3.2.1 Evolution of CRRT From A Simple Renal Replacement Treatment to A Multi-Organ Support Therapy (Most)
                               5.2.3.2.2 Progression of CRRT From Adaptive Renal Devices to Multipurpose Treatment Machines
                    5.2.3.3 Ongoing Research to Establish Safety and Efficacy Profile of CRRT
                    5.2.3.4 Development of CRRT System for Pediatric Patients
                               5.2.3.4.1 The Carpediem Project
                    5.2.3.5 Untapped Growth Opportunities in North American Market
           5.2.4 Challenges
                    5.2.4.1 High Complexity of CRRT Therapy
                               5.2.4.1.1 Lack of Standard Treatment Guidelines in Developing Countries
                               5.2.4.1.2 Complications Associated With CRRT
                    5.2.4.2 Shortage of Trained Icu Nurses in Developed Countries
                    5.2.4.3 Poor Reimbursement Scenario in Developing Countries
                    5.2.4.4 Lack of Awareness About Benefits of CRRT

6 Industry Insights (Page No. - 50)
    6.1 Introduction
    6.2 Reimbursement Scenario
           6.2.1 North America
           6.2.2 Europe
           6.2.3 Asia Pacific (Excluding Japan)
           6.2.4 Japan
           6.2.5 Rest of the World (RoW)
    6.3 Regulatory Landscape
           6.3.1 North America
           6.3.2 Europe
           6.3.3 Asia Pacific
           6.3.4 Rest of the World (RoW)
           6.3.5 Industry Trends
                    6.3.5.1 Training Programs for Operation of CRRT Devices
                    6.3.5.2 Rising Adoption of User-Friendly CRRT Machines
                    6.3.5.3 Development of A CRRT System for Pediatric Patients
    6.4 Porter’s Five Forces Analysis
           6.4.1 Competitive Intensity
           6.4.2 Bargaining Power of Buyers
           6.4.3 Bargaining Power of Suppliers
           6.4.4 Threat of Substitutes
           6.4.5 Threat of New Entrants
    6.5 Pricing and Cost Analysis
    6.6 Strategic Recommendations
           6.6.1 Design Recommendations
           6.6.2 Key Strategies for Players Seeking to Enter CRRT Market

7 Adoption of CRRT, By Region (Page No. - 64)
    7.1 Introduction
    7.2 Utilization of CRRT Procedures, By Region
    7.3 Number of CRRT Patients, By Region

8 CRRT Market, By Product (Page No. - 67)
    8.1 Introduction
           8.1.1 Dialysates and Replacement Fluids
           8.1.2 Disposables
                    8.1.2.1 Hemofilters
                    8.1.2.2 Bloodline Sets (Tubing Sets)
                    8.1.2.3 Other Disposables
           8.1.3 Systems

9 CRRT Market, By Modality (Page No. - 78)
    9.1 Introduction
    9.2 Continuous Venovenous Hemofiltration (CVVH)
    9.3 Continuous Venovenous Hemodiafiltration (CVVHDF)
    9.4 Continuous Venovenous Hemodialysis (CVVHD)
    9.5 Slow Continuous Ultrafiltration (SCUF)

10 CRRT Market, By Region (Page No. - 90)
     10.1 Introduction
     10.2 Europe
             10.2.1 Approval of CRRT Machines for Multiple Applications
             10.2.2 Intensivist Preference for CRRT for AKI Treatment
             10.2.3 Players Focus on Leveraging Growth Opportunities in Europe
             10.2.4 Germany
                        10.2.4.1 Increasing Focus of Players on German CRRT Market
                        10.2.4.2 Favorable Reimbursement for CRRT
             10.2.5 U.K.
                        10.2.5.1 Rising Awareness About AKI in the U.K.
             10.2.6 France
                        10.2.6.1 Significant Number of Ongoing Clinical Studies
             10.2.7 Rest of Europe (RoE)
     10.3 North America
             10.3.1 High Preference for Other Dialysis Modalities
             10.3.2 Regulatory Policies A Key Hindrance to Market Growth
             10.3.3 U.S.
                        10.3.3.1 Growth in AKI Prevalence
                        10.3.3.2 New Product Development to Boost Demand for CRRT Products
                        10.3.3.3 Ongoing Clinical Trials to Prove Safety and Efficacy of CRRT Products
                        10.3.3.4 Shortage of Registered Nurses in Icu Settings
             10.3.4 Canada
                        10.3.4.1 Rising AKI Prevalence
                        10.3.4.2 High Cost of CRRT as Compared to Ihd
     10.4 Asia Pacific
             10.4.1 Increasing Number of Sepsis Cases in India
             10.4.2 Studies and Clinical Trials to Establish Safety and Efficacy Profile of CRRT
             10.4.3 Unfavorable Reimbursement Scenario
             10.4.4 Japan
                        10.4.4.1 Increasing Use of CRRT for Non-Renal Indications
                        10.4.4.2 Well-Established Healthcare System
                        10.4.4.3 Large Number of Domestic Manufacturers Acts as Barrier to Entry of Major Players
             10.4.5 China
                        10.4.5.1 Rising Incidence of AKI and Esrd in China
                        10.4.5.2 Ongoing Research Studies
             10.4.6 India
                        10.4.6.1 Rising Sepsis Cases in India
                        10.4.6.2 Increase in Number of Dialysis Patients
                        10.4.6.3 Rising Number of Patients Admitted to Icus
                        10.4.6.4 Unfavorable Reimbursement Scenario
                        10.4.6.5 Lack of Randomized Trials and Dearth of Technical Expertise
                        10.4.6.6 Dearth of Indigenous Manufacturers of CRRT Products in India
             10.4.7 Rest of Asia Pacific (RoAPAC)
                        10.4.7.1 Taiwan A Lucrative Market for CRRT Players
     10.5 Rest of the World (RoW)
             10.5.1 Latin America and the Middle East
             10.5.2 New Amendments Open Brazilian Healthcare Industry to Foreign Investment

11 Competitive Landscape (Page No. - 124)
     11.1 Introduction
             11.1.1 Visionary Leaders
             11.1.2 Innovators
             11.1.3 Dynamic Differentiators
             11.1.4 Emerging Companies
     11.2 Strength of Product Portfolio
     11.3 Business Strategy Excellence
     11.4 Competitive Intensity
             11.4.1 Evaluation Parameters and Scores
             11.4.2 Scoring Methodology
             11.4.3 Competitive Intensity Score, By Company
                        11.4.3.1 Baxter International Inc.
                        11.4.3.2 Fresenius Medical Care AG & Co. KGaA
                        11.4.3.3 Nikkiso Co., Ltd.
                        11.4.3.4 B. Braun Melsungen AG
                        11.4.3.5 Nxstage Medical, Inc.
             11.4.4 Competitive Intensity – Mapping of Baxter International Inc., Fresenius Medical Care AG & Co. KGaA, Nikkiso Co., Ltd., B. Braun Melsungen AG, and Nxstage Medical, Inc.

*Top 25 Companies Analyzed for This Studies are - Baxter International Inc. (U.S.), Fresenius Medical Care AG & Co. KGaA (Germany), Nxstage Medical, Inc. (U.S.), Nikkiso Co., Ltd. (Japan), B. Braun Melsungen AG (Germany), Asahi Kasei Corporation (Japan), BeLLCo S.R.L. (Italy), Toray Medical Co., Ltd. (Japan), Infomed Sa (Switzerland), Medica S.P.A. (Italy), Medical Components, Inc. (U.S.), Medites Pharma Spol. S.R.O. (Czech Republic), Medtronic PLC (Ireland), SWS Hemodialysis Care Co., Ltd. (China), Ningbo Tianyi Medical Devices Co., Ltd (China), Cytosorbents Corporation (U.S.), Biomedica Spol. S R.O. (Czech Republic), Anjue Medical Equipment Co., Ltd. (China), Jiangxi Sanxin Medtec Co., Ltd. (China), Proxima Medicare (India), Nipro Corporation (Japan), Cytopherx, Inc. (U.S.), Dialysis Solutions Inc. (U.S.), Kimal Electronics Ltd (U.K.), Bl Lifesciences (India)

12 Company Profiles (Page No. - 136)
(Overview, Products Offered, Product Offering Scorecard, Business Strategy Scorecard, Recent Developments)*
     12.1 Baxter International Inc.
     12.2 Fresenius Medical Care AG & Co. KGaA
     12.3 Nikkiso Co., Ltd.
     12.4 Nxstage Medical, Inc.
     12.5 B. Braun Melsungen AG
     12.6 Asahi Kasei Medical Co., Ltd. (A Subsidiary of Asahi Kasei Corporation)
     12.7 BeLLCo S.R.L. (A Part of Medtronic PLC)
     12.8 Toray Medical Co., Ltd.
     12.9 Infomed Sa
     12.10 Medica S.P.A.
     12.11 Medical Components, Inc.
     12.12 Medites Pharma Spol. S.R.O.
     12.13 Medtronic PLC
     12.14 SWS Hemodialysis Care Co. Ltd.
     12.15 Ningbo Tianyi Medical Appliance Co., Ltd.

*Details on Marketsandmarkets View, Overview, Products Offered, Product Offering Scorecard, Business Strategy Scorecard, and Recent Developments Might Not Be Captured in Case of Unlisted Companies.

13 Appendix (Page No. - 177)
     13.1 Insights of Industry Experts
     13.2 Discussion Guide
     13.3 Knowledge Store: Marketsandmarkets’ Subscription Portal
     13.4 Introducing RT: Real-Time Market Intelligence
     13.5 Available Customizations
     13.6 Related Reports
     13.7 Author Details


List of Tables (65 Tables)

Table 1 Continuous Renal Replacement Therapy Machine Asp, By Manufacturer, 2016 (USD)
Table 2 CRRT Bloodlines and Dialysate Bags Asp, 2016 (USD)
Table 3 Market, By Product, 2015–2022 (USD Million)
Table 4 CRRT Dialysates & Replacement Fluids Market, By Region, 2015–2022 (USD Million)
Table 5 Europe: CRRT Dialysates & Replacement Fluids Market, By Country, 2015–2022 (USD Million)
Table 6 North America: CRRT Dialysates & Replacement Fluids Market, By Country, 2015–2022 (USD Million)
Table 7 Asia-Pacific: CRRT Dialysates & Replacement Fluids Market, By Country, 2015–2022 (USD Million)
Table 8 CRRT Disposables Market, By Type, 2015–2022 (USD Million)
Table 9 CRRT Disposables Market, By Region, 2015–2022 (USD Million)
Table 10 Europe: CRRT Disposables Market, By Country, 2015–2022 (USD Million)
Table 11 North America: CRRT Disposables Market, By Country, 2015–2022 (USD Million)
Table 12 Asia-Pacific: CRRT Disposables Market, By Country, 2015–2022 (USD Million)
Table 13 CRRT Systems Market, By Region, 2015–2022 (USD Million)
Table 14 Europe: CRRT Systems Market, By Country, 2015–2022 (USD Million)
Table 15 North America: CRRT Systems Market, By Country, 2015–2022 (USD Million)
Table 16 Asia-Pacific: CRRT Systems Market, By Country, 2015–2022 (USD Million)
Table 17 CRRT Market, By Modality, 2015–2022 (USD Million)
Table 18 CRRT Market for CVVH, By Region, 2015–2022 (USD Million)
Table 19 Europe: CRRT Market for CVVH, By Country, 2015–2022 (USD Million)
Table 20 North America: CRRT Market for CVVH, By Country, 2015–2022 (USD Million)
Table 21 Asia-Pacific: CRRT Market for CVVH, By Country, 2015–2022 (USD Million)
Table 22 CRRT Market for CVVHDF, By Region, 2015–2022 (USD Million)
Table 23 Europe: CRRT Market for CVVHDF, By Country, 2015–2022 (USD Million)
Table 24 North America: CRRT Market for CVVHDF, By Country, 2015–2022 (USD Million)
Table 25 Asia-Pacific: CRRT Market for CVVHDF, By Country, 2015–2022 (USD Million)
Table 26 CRRT Market for CVVHD, By Region, 2015–2022 (USD Million)
Table 27 Europe: CRRT Market for CVVHD, By Country, 2015–2022 (USD Million)
Table 28 North America: CRRT Market for CVVHD, By Country, 2015–2022 (USD Million)
Table 29 Asia-Pacific: CRRT Market for CVVHD, By Country, 2015–2022 (USD Million)
Table 30 CRRT Market for Scuf, By Region, 2015–2022 (USD Million)
Table 31 Europe: CRRT Market for Scuf, By Country, 2015–2022 (USD Million)
Table 32 North America: CRRT Market for Scuf, By Country, 2015–2022 (USD Million)
Table 33 Asia-Pacific: CRRT Market for Scuf, By Country, 2015–2022 (USD Million)
Table 34 CRRT Market, By Region, 2015–2022 (USD Million)
Table 35 Europe: Market, By Country, 2015–2022 (USD Million)
Table 36 Europe: Market, By Product, 2015–2022 (USD Million)
Table 37 Europe: Market, By Modality, 2015–2022 (USD Million)
Table 38 Germany: Market, By Product, 2013-2020 (USD Million)
Table 39 Germany: Market, By Modality, 2015–2022 (USD Million)
Table 40 U.K.: Continuous Renal Replacement Therapy Market, By Product, 2015–2022 (USD Million)
Table 41 U.K.: Market, By Modality, 2015–2022 (USD Million)
Table 42 France: Market, By Product, 2015–2022 (USD Million)
Table 43 France: Market, By Modality, 2015–2022 (USD Million)
Table 44 RoE: CRRT Market Size, By Product, 2015–2022 (USD Million)
Table 45 RoE: CRRT Market Size, By Modality, 2015–2022 (USD Million)
Table 46 North America: Market, By Country, 2015–2022 (USD Million)
Table 47 North America: CRRT Market, By Product, 2015–2022 (USD Million)
Table 48 North America: Market, By Modality, 2015–2022 (USD Million)
Table 49 U.S.: Market, By Product, 2015–2022 (USD Million)
Table 50 U.S.: Market, By Modality, 2015–2022 (USD Million)
Table 51 Canada: Market, By Product, 2015–2022 (USD Million)
Table 52 Canada: Continuous Renal Replacement Therapy Market, By Modality, 2015–2022 (USD Million)
Table 53 Asia Pacific: CRRT Therapy Market, By Country, 2015–2022 (USD Million)
Table 54 Asia Pacific: Market, By Product, 2015–2022 (USD Million)
Table 55 Asia Pacific: Market, By Modality, 2015–2022 (USD Million)
Table 56 Japan: Continuous Renal Replacement Therapy (CRRT) Market, By Product, 2015–2022 (USD Million)
Table 57 Japan: Market, By Modality, 2015–2022 (USD Million)
Table 58 China: Market, By Product, 2015–2022 (USD Million)
Table 59 China: Market, By Modality, 2015–2022 (USD Million)
Table 60 India: CRRT Therapy Market, By Product, 2015–2022 (USD Million)
Table 61 India: Market, By Modality, 2015–2022 (USD Million)
Table 62 RoAPAC: Market, By Product, 2015–2022 (USD Million)
Table 63 RoAPAC: Market, By Modality, 2015–2022 (USD Million)
Table 64 RoW: Continuous Renal Replacement Therapy Market, By Product, 2015–2022 (USD Million)
Table 65 RoW: CRRT Market, By Modality, 2015–2022 (USD Million)


List of Figures (52 Figures)

Figure 1 Global CRRT Market: Research Methodology Steps
Figure 2 Research Design
Figure 3 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 4 CRRT Market: Key Insights From Supply-Side Participants
Figure 5 CRRT Market: Key Insights From Demand–Side Participants
Figure 6 Estimation of CRRT Procedural Volume
Figure 7 Research Methodology: Top-Down Approach [For Market Size Estimation of CRRT Disposables (Bloodline Sets, Hemofilters, and Other Disposables)]
Figure 8 Research Methodology: Top-Down Approach (For Market Size Estimation of CRRT Systems)
Figure 9 Research Methodology: Bottom-Up Approach (For Estimation of CRRT Market Size)
Figure 10 Data Triangulation Steps (Top-Down and Bottom-Up Approaches)
Figure 11 Data Triangulation Methodology
Figure 12 Global CRRT Market By Product, 2017-2022 (USD Million)
Figure 13 Hemofilters Segment to Hold Largest Share of CRRT Disposables Market in 2017 (USD Million)
Figure 14 CVVHDF to Be the Fastest-Growing CRRT Modality During Forecast Period
Figure 15 Asia Pacific CRRT Market to Record Highest Growth During Forecast Period
Figure 16 Rising Prevalence of AKI to Drive Global CRRT Market During Forecast Period
Figure 17 Dialysates & Replacement Fluids to Dominate Global CRRT Products Market During Forecast Period
Figure 18 Europe to Dominate Global CRRT Market Across All Modalities in 2017
Figure 19 Europe to Dominate Global CRRT Market During Forecast Period
Figure 20 CRRT Market: Drivers, Restraints, Opportunities, and Challenges
Figure 21 Global Incidence of AKI Cases, 2010 vs 2015 vs 2020
Figure 22 Key Non-Renal Applications of CRRT
Figure 23 CRRT-Associated Technical and Clinical Complications
Figure 24 Key Factors Affecting Reimbursement Rates for CRRT Procedures
Figure 25 Global CRRT Reimbursement Scenario (2016)
Figure 26 Medical Reimbursement Structure in Europe
Figure 27 Global Regulatory Bodies for Approval of New CRRT Products
Figure 28 Porter’s Five Forces Analysis – Global CRRT Market
Figure 29 Design Recommendations for CRRT Machines
Figure 30 Utilization of CRRT vs Ihd and Sledd for Treatment of Renal Patients in Icus, By Region (2016)
Figure 31 Number of CRRT Patients Across the Globe, 2016
Figure 32 Global CRRT Market, By Product (2017 vs 2022)
Figure 33 CRRT Blood Purification Modalities
Figure 34 Global CRRT Market, By Modality (2017 vs 2022)
Figure 35 Europe to Dominate Global CRRT Market During Forecast Period (USD Million)
Figure 36 Europe: CRRT Market Snapshot
Figure 37 North America: CRRT Market Snapshot
Figure 38 Asia Pacific: CRRT Market Snapshot
Figure 39 RoW: CRRT Market Snapshot
Figure 40 Competitive Leadership Mapping
Figure 41 Global CRRT Market Share, By Key Player (2016)
Figure 42 Scoring Methodology
Figure 43 Comparison of Competitive Intensity Scores
Figure 44 Relative Positioning of Companies Based on Competitive Intensity Score and Focus on CRRT
Figure 45 Baxter International Inc.: Company Snapshot (2016)
Figure 46 Fresenius Medical Care AG & Co. KGaA: Company Snapshot (2016)
Figure 47 Nikkiso Co., Ltd.: Company Snapshot (2015)
Figure 48 Nxstage Medical, Inc.: Company Snapshot (2016)
Figure 49 B. Braun Melsungen AG: Company Snapshot (2016)
Figure 50 Asahi Kasei Corporation: Company Snapshot (2015)
Figure 51 Toray Industries, Inc.: Company Snapshot (2016)
Figure 52 Medtronic PLC.: Company Snapshot (2016)

The global Continuous Renal Replacement Therapy market is projected to reach USD 1.53 Billion by 2022 from USD 1.09 Billion in 2017, at a CAGR of 7.0%. Growing number of ICU patients, increasing incidence of sepsis, rising incidence of acute kidney injuries, technological advancements, and clinical advantages of CRRT over intermittent blood purification techniques are some of the key factors driving the growth of the market.

This market is segmented based on product, and modality. On the basis of product, the market is segmented into CRRT systems, disposables, and dialysates & replacement fluids, in which dialysates and replacement fluids is expected to account for the largest share of the market. This is attributed to the large volume of these products required during CRRT procedures.

Based on modality, the market is segmented into slow continuous ultrafiltration (SCUF), continuous venovenous hemofiltration (CVVH), continuous venovenous hemodialysis (CVVHD), and continuous venovenous hemodiafiltration (CVVHDF). The CVVH segment is estimated to command the larger share of the global CRRT market due to the wide adoption of this modality among healthcare providers owing to its wide range of advantages (such as removal of solutes in large quantities, easy fluid balance maintenance, and superior outcomes) over other CRRT modalities.

Continuous Renal Replacement Therapy (CRRT) Market

The report covers the market across four major geographies, namely, North America, Europe, Asia-Pacific, and the Rest of the World (RoW). Europe is expected to command the largest share of the market in 2017. However, Asia-Pacific is expected to register the highest growth rate during the forecast period due to the large acute kidney injury patient population, high utilization of CRRT in Australia and Japan, and improving healthcare infrastructure across Asian countries.

However, high procedural cost of CRRT and stringent regulatory guidelines for CRRT in North America are the major factors restraining the growth of this market.

The major players in the continuous renal replacement therapy market are Baxter International Inc. (U.S.), Fresenius Medical Care AG & Co. KGaA (Germany), Nikkiso Co., Ltd. (Japan), B. Braun Melsungen AG (Germany), Bellco S.r.l. (Italy), NxStage Medical, Inc. (U.S.), Asahi Kasei Corporation (Japan), Infomed SA (Switzerland), Medica S.p.A. (Italy), and Toray Medical Co., Ltd. (Japan).

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Please visit https://www.marketsandmarkets.com/knowledge-process-outsourcing-services.asp to specify your custom Research Requirement


-
Request for FREE Sample of this report Send Request